Halofantrine
-
Halofantrine
structure -
-
CAS No:
69756-53-2
-
Formula:
C26H30Cl2F3NO
-
Chemical Name:
Halofantrine
-
Synonyms:
9-Phenanthrenemethanol,1,3-dichloro-α-[2-(dibutylamino)ethyl]-6-(trifluoromethyl)-;1,3-Dichloro-α-[2-(dibutylamino)ethyl]-6-(trifluoromethyl)-9-phenanthrenemethanol;Halofantrine;Halfan;dl-WR 171669;(±)-Halofantrine;66051-63-6
- Categories:
-
CAS No:
Description
Solid
Solid
3-(dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)-9-phenanthrenyl]-1-propanol is a member of phenanthrenes.|Halofantrine is an antimalarial. It belongs to the phenanthrene class of compounds that includes quinine and lumefantrine. It appears to inhibit polymerisation of heme molecules (by the parasite enzyme "heme polymerase"), resulting in the parasite being poisoned by its own waste. Halofantrine has been shown to preferentially block open and inactivated HERG channels leading to some degree of cardiotoxicity.
Halofantrine Basic Attributes
500.42
500.42
274-104-1
DTXSID0023119
P - Antiparasitic products, insecticides and repellents
Characteristics
23.5
8.9
White solid
1.244 g/cm3
136-138ºC
596.2ºC at 760 mmHg
314.4ºC
1.577
0.59mg/L(37 ºC)
Toxicity
Side effects incldue coughing noisy, rattling, troubled breathing, loss of appetite, aches and pain in joints, indigestion,and skin itching or rash.
60-70%;
Drug Information
For treatment of Severe malaria|FDA Label
Halofantrine is a synthetic antimalarial which acts as a blood schizonticide. It is effective against multi drug resistant (including mefloquine resistant) P. falciparum malaria.
Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)
Hepatic
6-10 days
The mechanism of action of Halofantrine may be similar to that of chloroquine, quinine, and mefloquine; by forming toxic complexes with ferritoporphyrin IX that damage the membrane of the parasite.
1-(1,3-dichloro-6-trifluoromethyl-9-phenanthryl)-3-di(n-butyl)aminopropanol HCl
Halofantrine Use and Manufacturing
2, 4-Dichloro-6-nitrobenzaldehyde and 4-trifluoromethylphenylacetic acid are condensed to obtain compound (I). Then reduce the nitro group to an amino group to obtain compound (II). Diazotization of nitrous acid is performed first, and then the ring is coupled to synthesize phenanthrene ring (Ⅲ) under the action of strong acid. This is a classic: Pschorr reaction. Then it is reduced to alcohol, and then oxidized to aldehyde (V) with lead acetate. Reformatski condensation is carried out with N, N-di-n-butyl bromoacetamide and zinc, and the product is reduced with diborane to obtain halofantrine. Under stirring, 14.0 g of halofantrine was added to a 50% aqueous solution containing 4.8 g of β-glycerophosphonic acid, 500 ml of ethanol was added, and the mixture was heated at about 100°C. The precipitated white precipitate was collected by filtration to obtain halofantrine glycerol phosphonate.
It is an old antimalarial drug discovered in the 1930s. Plasmodium falciparum is as effective as chloroquine and can cure patients infected with chloroquine-resistant parasites. Used for malaria.
Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients
Computed Properties
Molecular Weight:500.4
XLogP3:8.6
Hydrogen Bond Donor Count:1
Hydrogen Bond Acceptor Count:5
Rotatable Bond Count:10
Exact Mass:499.1656545
Monoisotopic Mass:499.1656545
Topological Polar Surface Area:23.5
Heavy Atom Count:33
Complexity:584
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Recommended Suppliers of Halofantrine
-
CN
5 YRS
Business licensed Certified factoryManufactory Supplier of fine chemicals,pharmaceutical materials
Learn More Other Chemicals
-
Praziquantel
55268-74-1
-
Moxidectin
113507-06-5
-
1-(4-Aminophenyl)-2,3-dihydro-1,3,3-trimethyl-1H-inden-5-amine
54628-89-6
-
Monensin Formula
17090-79-8
-
Pyridinium, 1-ethyl-2,6-bis[2-[4-(1-pyrrolidinyl)phenyl]ethenyl]-, iodide (1:1) Formula
3784-99-4
-
Hydroxystilbamidine Formula
495-99-8
-
Sodium stibogluconate Structure
16037-91-5
-
Oxamniquine Structure
21738-42-1
-
What is Furodazole
56119-96-1
-
What is Bephenium hydroxynaphthoate
3818-50-6